BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 26228002)

  • 1. Importance of Ventricular Tachycardia Induction and Mapping for Patients Referred for Epicardial Ablation.
    Nazer B; Woods C; Dewland T; Moyers B; Badhwar N; Gerstenfeld EP
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1333-42. PubMed ID: 26228002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial only mapping and ablation of ventricular tachycardia: a case series.
    Berte B; Yamashita S; Sacher F; Cochet H; Hooks D; Aljefairi N; Amraoui S; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P
    Europace; 2016 Feb; 18(2):267-73. PubMed ID: 25840285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological mapping and radiofrequency catheter ablation for ventricular tachycardia in a patient with peripartum cardiomyopathy.
    Tokuda M; Stevenson WG; Nagashima K; Rubin DA
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1299-301. PubMed ID: 24102817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?
    Schmidt B; Chun KR; Baensch D; Antz M; Koektuerk B; Tilz RR; Metzner A; Ouyang F; Kuck KH
    Heart Rhythm; 2010 Dec; 7(12):1746-52. PubMed ID: 20709191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
    Reithmann C; Herkommer B; Fiek M
    Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An underrecognized subepicardial reentrant ventricular tachycardia attributable to left ventricular aneurysm in patients with normal coronary arteriograms.
    Ouyang F; Antz M; Deger FT; Bänsch D; Schaumann A; Ernst S; Kuck KH
    Circulation; 2003 Jun; 107(21):2702-9. PubMed ID: 12743007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Anter E; Hutchinson MD; Deo R; Haqqani HM; Callans DJ; Gerstenfeld EP; Garcia FC; Bala R; Lin D; Riley MP; Litt HI; Woo JY; Acker MA; Szeto WY; Zado ES; Marchlinski FE; Dixit S
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):494-500. PubMed ID: 21673018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia.
    Aryana A; d'Avila A; Heist EK; Mela T; Singh JP; Ruskin JN; Reddy VY
    Circulation; 2007 Mar; 115(10):1191-200. PubMed ID: 17296855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation: pragmatic approach favoring late potentials abolition.
    Tsiachris D; Silberbauer J; Maccabelli G; Oloriz T; Baratto F; Mizuno H; Bisceglia C; Vergara P; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):863-73. PubMed ID: 26022186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach.
    Sultan A; Lüker J; Hoffmann B; Servatius H; Aydin A; Nührich J; Akbulak Ö; Schreiber D; Schäffer B; Rostock T; Willems S; Steven D
    Int J Cardiol; 2015 Mar; 182():56-61. PubMed ID: 25576719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
    Dukkipati SR; d'Avila A; Soejima K; Bala R; Inada K; Singh S; Stevenson WG; Marchlinski FE; Reddy VY
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):185-94. PubMed ID: 21270104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditis.
    Maccabelli G; Tsiachris D; Silberbauer J; Esposito A; Bisceglia C; Baratto F; Colantoni C; Trevisi N; Palmisano A; Vergara P; De Cobelli F; Del Maschio A; Della Bella P
    Europace; 2014 Sep; 16(9):1363-72. PubMed ID: 24558183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.